The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Criteria for the classification of giant cell (temporal) arteritis were developed by comparing 214 patients who had this disease with 593 patients with other forms of vasculitis. For the traditional format classification, 5 criteria were selected: age ≥50 years at disease onset, new onset of localized headache, temporal artery tenderness or decreased temporal artery pulse, elevated erythrocyte sedimentation rate (Westergren) ≥50 mm/hour, and biopsy sample including an artery, showing necrotizing arteritis, characterized by a predominance of mononuclear cell infiltrates or a granulomatous process with multinucleated giant cells. The presence of 3 or more of these 5 criteria was associated with a sensitivity of 93.5% and a specificity of 91.2%. A classification tree was also constructed using 6 criteria. These criteria were the same as for the traditional format, except that elevated erythrocyte sedimentation rate was excluded, and 2 other variables were included: scalp tenderness and claudication of the jaw or tongue or on deglutition. The classification tree was associated with a sensitivity of 95.3% and specificity of 90.7%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Temporal Arteritis: A 25-Year Epidemiologic, Clinical, and Pathologic Study
HUSTON, K. A., HUNDER, G. G., LIE, J. T., KENNEDY, R. H., & ELVEBACK, L. R. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-2-162 · Cited by 547
Self-citationIllustrated histopathologic classification criteria for selected vasculitis syndromes
Lie, J. T. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330804 · Cited by 428
Self-citationHUNDER, G. G., SHEPS, S. G., ALLEN, G. L., & JOYCE, J. W. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-5-613 · Cited by 299
Self-citationGiant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a danish county
Boesen, P., & Sørensen, S. F. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300308 · Cited by 203
Clinical Manifestations of Giant Cell (Temporal) Arteritis
CALAMIA, K. T., & Hunder, G. G. (1980) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00303-9 · Cited by 148
Self-citationAcute Phase Reactants in the Initial Phase of Giant Cell Arteritis
Andersson, R., Malmvall, B., & Bengtsson, B. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02779.x · Cited by 41
Cited by
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Jennette, J. C., Falk, R. J., Bacon, P. A., Basu, N., Cid, M. C., Ferrario, F., Flores‐Suarez, L. F., Gross, W. L., Guillevin, L., Hagen, E. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37715 · Cited by 6,631
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Self-citationErbel (2014) · doi:10.1093/eurheartj/ehu281 · Cited by 4,451
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Self-citationWRITING GROUP MEMBERS, Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4739e · Cited by 2,289
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.015 · Cited by 1,692
Trial of tocilizumab in giant-cell arteritis
Stone, J. H., Tuckwell, K., Dimonaco, S., Klearman, M., Aringer, M., Blockmans, D., Brouwer, E., Cid, M. C., Dasgupta, B., Rech, J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613849 · Cited by 1,386
Polymyalgia Rheumatica and Giant-Cell Arteritis
Salvarani, C., Cantini, F., Boiardi, L., & Hunder, G. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011913 · Cited by 1,352
Self-citationEditor's Choice – Management of Descending Thoracic Aorta Diseases
Riambau, V., Böckler, D., Brunkwall, J., Cao, P., Chiesa, R., Coppi, G., Czerny, M., Fraedrich, G., Haulon, S., Jacobs, M. J., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2016.06.005 · Cited by 1,246
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d47d48 · Cited by 999
Polymyalgia rheumatica and giant-cell arteritis
Salvarani, C., Cantini, F., & Hunder, G. G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61077-6 · Cited by 767
Self-citationPolymyalgia Rheumatica and Giant Cell Arteritis
Ettlinger, R. E., Hunder, G. G., & Ward, L. E. (1978) · Annual Review of Medicine · doi:10.1146/annurev.me.29.020178.000311 · Cited by 687
Self-citationHayreh, S. S. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.11.002 · Cited by 656
Crowson, C. S., Matteson, E. L., Myasoedova, E., Michet, C. J., Ernste, F. C., Warrington, K. J., Davis, J. M., Hunder, G. G., Therneau, T. M., & Gabriel, S. E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30155 · Cited by 638
Self-citationGlucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
Proven, A., Gabriel, S. E., Orces, C., O'Fallon, W. M., & Hunder, G. G. (2003) · Arthritis Care & Research · doi:10.1002/art.11388 · Cited by 612
Self-citationVilliger, P. M., Adler, S., Kuchen, S., Wermelinger, F., Dan, D., Fiege, V., Bütikofer, L., Seitz, M., & Reichenbach, S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00560-2 · Cited by 577
Nuenninghoff, D. M., Hunder, G. G., Christianson, T. J. H., McClelland, R. L., & Matteson, E. L. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11353 · Cited by 568
Self-citationHoffman, G. S., Cid, M. C., Rendt-Zagar, K. E., Merkel, P. A., Weyand, C. M., Stone, J. H., Salvarani, C., Xu, W., Visvanathan, S., Rahman, M. U., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00004 · Cited by 563
Gornik, H. L., & Creager, M. A. (2008) · Circulation · doi:10.1161/circulationaha.107.760686 · Cited by 505
The antineutrophil cytoplasmic antibody–associated vasculitides
Seo, P., & Stone, J. H. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.030 · Cited by 496
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review
Buttgereit, F., Dejaco, C., Matteson, E. L., & Dasgupta, B. (2016) · JAMA · doi:10.1001/jama.2016.5444 · Cited by 496
Luqmani, R., Lee, E., Singh, S., Gillett, M., Schmidt, W. A., Bradburn, M., Dasgupta, B., Diamantopoulos, A. P., Forrester-Barker, W., Hamilton, W., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20900 · Cited by 462
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
Erbel, R., Aboyans, V., Boileau, C., Bossone, E., Di Bartolomeo, R., Eggebrecht, H., Evangelista, A., Falk, V., Frank, H., Gaemperli, O., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0225 · Cited by 458
BSR and BHPR guidelines for the management of giant cell arteritis
Dasgupta, B., Borg, F. A., Hassan, N., Alexander, L., Barraclough, K., Bourke, B., Fulcher, J., Hollywood, J., Hutchings, A., James, P., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq039a · Cited by 444
Low‐dose aspirin and prevention of cranial ischemic complications in giant cell arteritis
Nesher, G., Berkun, Y., Mates, M., Baras, M., Rubinow, A., & Sonnenblick, M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20171 · Cited by 429
Giant Cell Arteritis: Validity and Reliability of Various Diagnostic Criteria
HAYREH, S. S., PODHAJSKY, P. A., RAMAN, R., & ZIMMERMAN, B. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70123-0 · Cited by 412
Giant-Cell Arteritis and Polymyalgia Rheumatica
Weyand, C. M., & Goronzy, J. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1214825 · Cited by 410
González-Gay, M. A., Blanco, R., Rodríguez-Valverde, V., Martínez-Taboada, V. M., Delgado-Rodriguez, M., Figueroa, M., & Uriarte, E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199808)41:8<1497::aid-art22>3.0.co;2-z · Cited by 408
Does This Patient Have Temporal Arteritis?
Smetana, G. W. (2002) · JAMA · doi:10.1001/jama.287.1.92 · Cited by 402
Bleeker-Rovers, C. P., Vos, F. J., de Kleijn, E. M. H. A., Mudde, A. H., Dofferhoff, T. S. M., Richter, C., Smilde, T. J., Krabbe, P. F. M., Oyen, W. J. G., & van der Meer, J. W. M. (2007) · Medicine · doi:10.1097/md.0b013e31802fe858 · Cited by 399
A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis
Langford, C. A., Cuthbertson, D., Ytterberg, S. R., Khalidi, N., Monach, P. A., Carette, S., Seo, P., Moreland, L. W., Weisman, M., Koening, C. L., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40044 · Cited by 394
Visual Prognosis in Giant Cell Arteritis
Aiello, P. D., Trautmann, J. C., McPhee, T. J., Kunselman, A. R., & Hunder, G. G. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31608-8 · Cited by 388
Self-citation2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
Ponte, C., Grayson, P. C., Robson, J. C., Suppiah, R., Gribbons, K. B., Judge, A., Craven, A., Khalid, S., Hutchings, A., Watts, R. A., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223480 · Cited by 388
Self-citationGiant-Cell Arteritis and Polymyalgia Rheumatica
Weyand, C. M., & Goronzy, J. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00015 · Cited by 379
Meta-Analysis: Test Performance of Ultrasonography for Giant-Cell Arteritis
Karassa, F. B., Matsagas, M. I., Schmidt, W. A., & Ioannidis, J. P. A. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00011 · Cited by 374
Dejaco, C., Duftner, C., Buttgereit, F., Matteson, E. L., & Dasgupta, B. (2016) · Rheumatology · doi:10.1093/rheumatology/kew273 · Cited by 365
Grayson, P. C., Alehashemi, S., Bagheri, A. A., Civelek, A. C., Cupps, T. R., Kaplan, M. J., Malayeri, A. A., Merkel, P. A., Novakovich, E., Bluemke, D. A., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40379 · Cited by 352
Mazlumzadeh, M., Hunder, G. G., Easley, K. A., Calamia, K. T., Matteson, E. L., Griffing, W. L., Younge, B. R., Weyand, C. M., & Goronzy, J. J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22163 · Cited by 347
Self-citationBlockmans, D., Stroobants, S., Maes, A., & Mortelmans, L. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00424-6 · Cited by 347
Roche, N. E., Fulbright, J. W., Wagner, A. D., Hunder, G. G., Goronzy, J. J., & Weyand, C. M. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360913 · Cited by 347
Self-citationRao, J. K., Allen, N. B., & Pincus, T. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-5-199809010-00001 · Cited by 338
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., et al. (2010) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22537 · Cited by 330
Giant Cell Arteritis: Disease Patterns of Clinical Presentation in a Series of 240 Patients
Gonzalez-Gay, M. A., Barros, S., Lopez-Diaz, M. J., Garcia-Porrua, C., Sanchez-Andrade, A., & Llorca, J. (2005) · Medicine · doi:10.1097/01.md.0000180042.42156.d1 · Cited by 322
Kermani, T. A., Warrington, K. J., Crowson, C. S., Ytterberg, S. R., Hunder, G. G., Gabriel, S. E., & Matteson, E. L. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202408 · Cited by 321
Self-citationGiant Cell Arteritis and Polymyalgia Rheumatica
Stone, J. R., Pless, M., Salvarani, C., Pipitone, N., Lessell, S., & Stone, J. H. (2009) · A Clinician's Pearls and Myths in Rheumatology · doi:10.1007/978-1-84800-934-9_27 · Cited by 308
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis
Lee, M. S., Smith, S. D., Galor, A., & Hoffman, G. S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22141 · Cited by 304
Duftner, C., Dejaco, C., Sepriano, A., Falzon, L., Schmidt, W. A., & Ramiro, S. (2018) · RMD Open · doi:10.1136/rmdopen-2017-000612 · Cited by 302
Smeeth, L., Cook, C., & Hall, A. J. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.046912 · Cited by 299
Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity
Weyand, C. M., Fulbright, J. W., Hunder, G. G., Evans, J. M., & Goronzy, J. J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1041::aid-anr12>3.0.co;2-7 · Cited by 299
Self-citationNew Onset of Autoimmune Diseases Following COVID-19 Diagnosis
Gracia-Ramos, A. E., Martin-Nares, E., & Hernández-Molina, G. (2021) · Cells · doi:10.3390/cells10123592 · Cited by 296
Hernandez-Rodriguez, J. (2003) · Rheumatology · doi:10.1093/rheumatology/keh058 · Cited by 295
Salvarani, C., Crowson, C. S., O'Fallon, W. M., Hunder, G. G., & Gabriel, S. E. (2004) · Arthritis Care & Research · doi:10.1002/art.20227 · Cited by 282
Self-citationUnizony, S., Arias‐Urdaneta, L., Miloslavsky, E., Arvikar, S., Khosroshahi, A., Keroack, B., Stone, J. R., & Stone, J. H. (2012) · Arthritis Care & Research · doi:10.1002/acr.21750 · Cited by 272
Salvarani, C., & Hunder, G. G. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200104)45:2<140::aid-anr166>3.0.co;2-2 · Cited by 266
Self-citationVisual Morbidity in Giant Cell Arteritis
Liu, G. T., Glaser, J. S., Schatz, N. J., & Smith, J. L. (1994) · Ophthalmology · doi:10.1016/s0161-6420(94)31102-x · Cited by 259
Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment
Borchers, A. T., & Gershwin, M. E. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.01.003 · Cited by 256
Seror, R., Baron, G., Hachulla, E., Debandt, M., Larroche, C., Puéchal, X., Maurier, F., de Wazieres, B., Quéméneur, T., Ravaud, P., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203586 · Cited by 256
What is known about the epidemiology of the vasculitides?
Watts, R. A., Lane, S., & Scott, D. G. I. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2004.11.006 · Cited by 178
(2004) · doi:10.1191/0961203304lu511xx · Cited by 7
Metadata
- Authors
- Hunder, G. G., Bloch, D. A., Michel, B. A., Stevens, M. B., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., Lie, J. T., Lightfoot, R. W., Masi, A. T., McShane, D. J., Mills, J. A., Wallace, S. L., & Zvaifler, N. J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1990-08
- Volume
- 33
- Issue
- 8
- Pages
- 1122-1128
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1987316799
- Cited by
- 2,539
- References
- 6
- FWCI
- 13.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.